-
Entering Functional Restoration Programs for Chronic Low Back Pain is Delayed when Patients do not Receive Support at Work: a study of 185 patients in France Joint Bone Spine (IF 4.2) Pub Date : 2024-03-12 Laetitia Marson, Sabrina Dadoun, Fanny Roure, Sylvie Rozenberg, Marc Marty, Laure Gossec, Bruno Fautrel, Violaine Foltz, spine section of the French Society of Rheumatology
-
Axial spondyloarthritis and inflammatory bowel disease: therapeutic implications Joint Bone Spine (IF 4.2) Pub Date : 2024-03-12 Philippe Goupille, Lucine Vuitton, Daniel Wendling
-
Corrigendum to “Epidemiology and predictors of relapse in giant cell arteritis: A systematic review and meta-analysis” [Joint Bone Spine 2023;90 :105494] Joint Bone Spine (IF 4.2) Pub Date : 2024-03-07 Lien Moreel, Albrecht Betrains, Geert Molenberghs, Steven Vanderschueren, Daniel Blockmans
-
Proton pump inhibitors, bone and phosphocalcic metabolism Joint Bone Spine (IF 4.2) Pub Date : 2024-03-06 Cécile Philippoteaux, Julien Paccou, Emmanuel Chazard, Bernard Cortet
Proton pump inhibitors (PPIs) are widely used for acid-related gastrointestinal disorders; however, concerns have arisen about their prolonged and inappropriate use. Although generally considered safe, recent evidence has linked PPI use with an increased risk of kidney disease, stomach cancer, pneumonia, dementia, cardiovascular events and potential bone health problems. This systematic review examines
-
Pitfalls and pearls in diagnosing inflammatory arthritis in older patients Joint Bone Spine (IF 4.2) Pub Date : 2024-03-05 Justin Levinson, Bjoern Buehring
Given current demographic shifts, the number of older adults continues to grow, with almost half of patients over 65 being diagnosed with some form of arthritis. Rheumatic diseases pose unique diagnostic challenges in older patients due to the convergence of physiologic changes of aging, confounding difficulties to care, and atypical disease manifestations. This review summarizes the current published
-
Ultrasound findings in secondary hypertrophic osteoarthropathy Joint Bone Spine (IF 4.2) Pub Date : 2024-03-05 Olivier Fakih, Frank Verhoeven, Clément Prati, Daniel Wendling
-
McCune-Albright syndrome: Beyond classical craniofacial deformities Joint Bone Spine (IF 4.2) Pub Date : 2024-03-05 Rafaela Nicolau, Tiago Beirão, Francisca Guimarães, Sara Ganhão, Francisca Aguiar, Mariana Rodrigues, Iva Brito
-
Examination of monosodium urate crystal depletion and bone erosion remodeling during pegloticase treatment in patients with uncontrolled gout: Exploratory dual-energy computed tomography findings from MIRROR RCT Joint Bone Spine (IF 4.2) Pub Date : 2024-03-04 Nicola Dalbeth, John Botson, Kenneth Saag, Ada Kumar, Lissa Padnick-Silver, Brian LaMoreaux, Fabio Becce
Monosodium-urate (MSU) crystal deposits can be visualized and quantified with dual-energy CT (DECT). Pegloticase lowers serum urate (SU) in uncontrolled gout patients, with methotrexate (MTX) co-therapy recommended to increase SU-lowering response rate and decrease infusion reaction risk. The literature on serial DECT-imaging during pegloticase+MTX co-therapy is sparse, with only 2 prior cases of rapid
-
Can methotrexate influence sexual dysfunction in male patients? Analysis of the IIEF5 questionnaire and hormonal status Joint Bone Spine (IF 4.2) Pub Date : 2024-03-04 Francesco Natalucci, Sandra Bisseron, Tatiana Sokolova, Aleksandra Avramovska, Dominique Maiter, Patrick Durez
The aim of this study is to evaluate the impact of MTX on erectile function in male patients through the International Index of Erectile Function (IIEF5) questionnaire and hormonal dosage. Male patients affected by inflammatory arthritis (rheumatoid arthritis [RA] or psoriatic arthritis [PsA]) with good disease control and treated with chronic MTX were enrolled. Age-matched patients affected by chronic
-
Issues with pregnancy in systemic lupus Joint Bone Spine (IF 4.2) Pub Date : 2024-03-04 Véronique Le Guern, Gaelle Guettrot-Imbert, Anastasia Dupré, Sandrine Perol, Emmanuelle Pannier, Nathalie Morel, Nathalie Costedoat-Chalumeau
Systemic lupus erythematosus is a disease that affects a large number of young women of childbearing age. Today, pregnancy is considered safe in almost all women with lupus, especially when the disease is under control. However, pregnancies in this population have a higher risk of maternal complications than in the general population. It is therefore important to plan pregnancies as effectively as
-
Gunshot acquired sciatica Joint Bone Spine (IF 4.2) Pub Date : 2024-02-22 Olivier Fakih, Frank Verhoeven, Clément Prati, Daniel Wendling
-
Intersection syndrome Joint Bone Spine (IF 4.2) Pub Date : 2024-02-22 Nurmuhammed Tas, Hayri Ogul, Mecit Kantarci
-
CAR-T cells for treating systemic lupus erythematosus: A promising emerging therapy Joint Bone Spine (IF 4.2) Pub Date : 2024-02-07 Aurélien Guffroy, Léa Jacquel, Blandine Guffroy, Thierry Martin
Chimeric Antigen Receptor T-cell therapy (CAR-T), currently employed routinely for treating B-cell malignancies, has emerged as a groundbreaking approach in addressing severe autoimmune diseases, especially for systemic lupus erythematosus (SLE). The immunological rationale for targeting B lymphocytes in autoimmune diseases is well-established, demonstrating success in numerous autoantibody-mediated
-
Early-onset gout Joint Bone Spine (IF 4.2) Pub Date : 2024-02-07 Tristan Pascart, Vincent Ducoulombier, Charlotte Jauffret
Early-onset gout (EOG) is characterized by the occurrence of the first symptoms of gout at an unusually young age, usually <40 years. The aim of this review is to provide an overview of the epidemiology, clinical presentation and prognosis, association with comorbidities and specific management of EOG. A particularly high proportion of patients with EOG come from ethnic groups with stronger genetic
-
Septic arthritis of the facet joint is also a severe vertebral infection: A multicenter retrospective study of 65 patients Joint Bone Spine (IF 4.2) Pub Date : 2024-02-07 Simon Cadiou, Rachel Tuil, Benoît Le Goff, Emmanuel Hoppé, Denis Mulleman, Camille Langbour, Estelle Le Pabic, Laurie Charret, Helene Cormier, Raphael Lecomte, Cédric Arvieux, Pascal Guggenbuhl
Septic arthritis of the Facet Joints (SAFJ) is a rare condition. Little data has been published on the subject. We aimed to describe the clinical, biological and imagery presentations, as well as the course of this rare infection. We included patients hospitalized between January 1st, 2016 and December 31th, 2019, in the Departments of Infectious Diseases or Rheumatology in 5 French centres in the
-
Targeted therapies for uveitis in spondyloarthritis: a narrative review Joint Bone Spine (IF 4.2) Pub Date : 2024-02-01 Robin Jacquot, Laurent Kodjikian, Roland Chapurlat, Pascal Sève
Spondyloarthritis (SpA) encompasses a group of chronic inflammatory disorders of the joints frequently associated with uveitis in almost a quarter of cases. SpA-related uveitis typically affects the eye anterior chamber with sudden onset, causing pain, redness, photophobia, and blurred vision. Ophthalmologists will describe an acute anterior unilateral uveitis. Most patients present with episodic acute
-
A rare case of intraosseous calcaneal lipoma with calcific and cystic components Joint Bone Spine (IF 4.2) Pub Date : 2024-02-02 Gökhan Tonkaz, Cemre Akdeniz, Mehmet Tonkaz, Duygu Erkal Tonkaz, Tumay Bekci
Abstract not available
-
Regulation of SOCS3-STAT3 in urate-induced cytokine production in human myeloid cells Joint Bone Spine (IF 4.2) Pub Date : 2024-02-02 Medeea Badii, Viola Klück, Orsolya Gaal, Georgiana Cabău, Ioana Hotea, Valentin Nica, Andreea M. Mirea, Anca Bojan, Mihnea Zdrenghea, Boris Novakovic, Tony R. Merriman, Zhaoli Liu, Yang Li, Cheng-Jian Xu, Cristina Pamfil, Simona Rednic, Radu A. Popp, Tania O. Crişan, Leo A.B. Joosten
Hyperuricaemia is necessary for gout. High urate concentrations have been linked to inflammation in mononuclear cells. Here, we explore the role of the suppressor of cytokine signaling 3 (SOCS3) in urate-induced inflammation. Peripheral blood mononuclear cells (PBMCs) from gout patients, hyperuricemic and normouricemic individuals were cultured for 24h with varying concentrations of soluble urate,
-
High-resolution peripheral quantitative computed tomography for the assessment of acro-osteolysis and calcinosis in patients with systemic sclerosis Joint Bone Spine (IF 4.2) Pub Date : 2024-02-02 Frederik Cosedis Enevoldsen, Josephine Therkildsen, Rasmus Klose-Jensen, Amanda Lynggaard Elkjær, Esben Uggerby Næser, Rikke Fuglsang Klicman, Katja Thorup Aaen, Klaus Henrik Søndergaard, Ellen-Margrethe Hauge
To assist the development of future treatments in systemic sclerosis (SSc), the development of reliable outcome measures is pivotal. We aimed to evaluate the use of high-resolution peripheral quantitative CT (HR-pQCT) for visualization and gradation of acroosteolysis (AO) and calcinosis compared to conventional hand radiographs (CR) in patients with SSc. HR-pQCT scans of the 2nd to 4th fingers, CR
-
Biology and physiology of tendon healing Joint Bone Spine (IF 4.2) Pub Date : 2024-02-01 Christelle Darrieutort Laffite, Frédéric Blanchard, Louis J Soslowsky, Benoit Le Goff
Tendon disorders affect people of all ages, from elite and recreational athletes and workers to elderly patients. After an acute injury, 3 successive phases are described to achieve healing: an inflammatory phase followed by a proliferative phase, and finally by a remodeling phase. Despite this process, healed tendon fails to recover its original mechanical properties. In this review, we proposed to
-
VEXAS syndrome: An update Joint Bone Spine (IF 4.2) Pub Date : 2024-02-01 Mohamed-Yacine Khitri, Jérôme Hadjadj, Arsène Mekinian, Vincent Jachiet
VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described autoinflammatory syndrome, mostly affecting men older than 50 years, caused by somatic mutation in the gene, a X-linked gene involved in the activation of ubiquitin system. Patients present a broad spectrum of inflammatory manifestations (fever, neutrophilic dermatosis, chondritis, pulmonary infiltrates
-
Hip involvement in Axial Spondylarthritis Patients: Comparison between Ankylosing Spondylitis and Non-radiographic Axial Spondylarthritis- A retrospective study Joint Bone Spine (IF 4.2) Pub Date : 2024-01-29 Sofia Ferreira Azevedo, Carolina Mazeda, Anabela Barcelos
Abstract not available
-
"If I have Sjögren's syndrome, I want to know it as early as possible": the perspective of first-degree relatives of patients with Sjögren's syndrome from an international survey Joint Bone Spine (IF 4.2) Pub Date : 2024-01-28 Alessia Alunno, Francesco Carubbi, Valentin Ritschl, Divi Cornec, Sabine Zenz, Ana Vieira, Katy Antonopoulou, Loukas Chatzis, Vasco C. Romão, Athanasios Tzioufas, Matilde Bandeira, Martin H Stradner
Abstract not available
-
Persistent remission of severe rheumatoid arthritis associated with myelodysplastic syndrome upon treatment with lenalidomide Joint Bone Spine (IF 4.2) Pub Date : 2024-01-19 Sandrine Carvès, Rudy Birsen, Jérôme Avouac
Abstract not available
-
Molecular portrait of chronic joint diseases: defining endotypes toward personalized medicine Joint Bone Spine (IF 4.2) Pub Date : 2024-01-19 Giulia Maria Ghirardi, Chiara Aurora Delrosso, Alessandra Nerviani, Marie-Astrid Boutet
Joint diseases affect hundreds of millions of people worldwide, and their prevalence is constantly increasing. To date, despite recent advances in the development of therapeutic options for most rheumatic conditions, a significant proportion of patients still lack efficient disease management, considerably impacting their quality of life. Through the spectrum of rheumatoid arthritis (RA), psoriatic
-
The “Charlot Sign/Moustache Sign‿: a new sign of Paget’s Disease of Bone Joint Bone Spine (IF 4.2) Pub Date : 2024-01-19 Carolina Ochôa Matos, José Carlos Romeu
Abstract not available
-
-
Osteoarthritis and Diabetes: Is There a True Link? Joint Bone Spine (IF 4.2) Pub Date : 2024-01-03 Alice Courties
Abstract not available
-
-
-
Ten-Year Clinical Outcome of recent-onset Axial Spondyloarthritis: results from the DESIR inception Cohort Joint Bone Spine (IF 4.2) Pub Date : 2023-12-30 Maxime Dougados, Chris Serrand, Sandrine Alonso, Francis Berenbaum, Pascal Claudepierre, Bernard Combe, Laure Gossec, Adeline Ruyssen Witrand, Alain Saraux, Daniel Wendling, Thierry Le Querré, Anna Molto
Objectives: This study aimed to evaluate the 10-year clinical outcome of patients with recent-onset axial spondyloarthritis (axSpA). Methods: Study design: The DESIR cohort is an inception cohort of axSpA patients. Diagnosis and Management: The diagnosis and management of patients were based on the decision of the treating rheumatologist. Statistical Analysis: Both complete cases and imputed data analyses
-
Molecular B cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren’s syndrome Joint Bone Spine (IF 4.2) Pub Date : 2023-12-29 Antoine Poulet, Audrey Benyamine, Pauline Belenotti, Hugo Nihous, Nicoleta Ene, Pierre André Jarrot, Laure Swiader, Julien Mancini, Meng Nathalie Beaufils, Arnaud Essaydi, Jean Gabert, Pierre Jean Weiller, Gilles Kaplanski
Objectives: Non-Hodgkin’s lymphoma (NHL) risk assessment is crucial in Sjögren’s syndrome (SS). We studied the prevalence of clonal immunoglobulin gene rearrangements in minor salivary glands (MSG) and their correlations with lymphoma occurrence and with previously established NHL predictors. Methods: Molecular B-cell expansion was studied in fresh frozen MSG of 207 patients with either suspected SS
-
Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: a 12 years follow up explorative study Joint Bone Spine (IF 4.2) Pub Date : 2023-12-29 Reinder Raadsen, Bas Dijkshoorn, Laurette van Boheemen, Edwin ten Boekel, Arno W R van Kuijk, Michael T Nurmohamed
Objectives: The aim of the current study was to explore the changes in lipid and NT-proBNP levels in rheumatoid arthritis (RA) patients through different phases of the disease: from the preclinical stage and RA onset up to the treatment phase with biological disease-modifying anti-rheumatic drugs (bDMARDS). Methods: Thirty-eight consecutive patients, initially with arthralgia and rheumatoid factor
-
A Fibrodysplasia Ossificans Progressiva Patient with a Rare Missense Mutation in ACVR1 Detected on 18F-FDG PET/CT Joint Bone Spine (IF 4.2) Pub Date : 2023-12-29 Haopeng Ni, Songhan Tang, Ying Zhang
Fibrodysplasia ossificans progressiva (FOP) is an exceedingly rare human genetic disorder characterized by the progressive and incapacitating formation of ectopic bone outside of the skeleton. We report a case of FOP patient with mutations within the ACVR1 gene (c.982G>A; p.G328R). 18F-FDG Positron emission tomography/computed tomography (PET/CT) was carried out for disease assessment. Previous studies
-
NSAID: Current limits to prescription Joint Bone Spine (IF 4.2) Pub Date : 2023-12-29 Theo Wirth, Pierre Lafforgue, Thao Pham
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed to alleviate pain and inflammation in conditions like arthritis, migraines, and post-operative recovery. Their mechanism involves inhibiting prostaglandins that contribute to inflammation. NSAIDs are categorized based on their structure, selectivity for COX-1 and COX-2 enzymes, and plasma half-life. They are effective in treating
-
Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: A cohort study using routinely collected health data Joint Bone Spine (IF 4.2) Pub Date : 2023-12-22 Yoshiya Tanaka, Shinichi Tanaka, Toshiki Fukasawa, Shoichiro Inokuchi, Hidetoshi Uenaka, Takeshi Kimura, Toshiya Takahashi, Naoto Kato
Objective: We aimed to describe the following in patients with polymyalgia rheumatica (PMR): (1) real-world glucocorticoid (GC) therapy, (2) improvement in inflammatory parameters associated with disease activity (C-reactive protein [CRP] level and erythrocyte sedimentation rate [ESR]), and (3) incidence of GC-related adverse events (AEs). Methods: A cohort study was conducted using a Japanese electronic
-
J-shaped association of serum uric acid concentrations with all-cause mortality in individuals with osteoarthritis: A prospective cohort study Joint Bone Spine (IF 4.2) Pub Date : 2023-12-22 Jinlong Zhao, Bangxin Sha, Lingfeng Zeng, Yaoxing Dou, Hetao Huang, Guihong Liang, Jianke Pan, Kunhao Hong, Guanghui Zhou, Weiyi Yang, Jun Liu
Objective: The purpose of this study was to explore the relationship between serum uric acid (SUA) concentrations and all-cause mortality in individuals with osteoarthritis (OA). Methods: All participant data were retrieved from the National Health and Nutrition Examination Survey database. A total of 4671 participants (age range: 20 to 85 years old), including 2988 females and 1683 males, were included
-
Integrating social and economic status in rheumatoid arthritis exposure studies Joint Bone Spine (IF 4.2) Pub Date : 2023-12-21 Johanna Sigaux, Luca Semerano, Marie-Christophe Boissier
Abstract not available
-
Cardiac conduction disorders in ankylosing spondylitis: a systematic literature review and meta-analyses of controlled studies Joint Bone Spine (IF 4.2) Pub Date : 2023-12-15 Mickaël Dalecky, Tiphaine Dujardin, Arnaud Pflimlin, Athan Baillet, Xavier Romand
Abstract not available
-
Thalassemia skull Joint Bone Spine (IF 4.2) Pub Date : 2023-12-15 Parag Vijaysingh Patil
Abstract not available
-
Facet joint involvement in the inflammatory rheumatic disease Joint Bone Spine (IF 4.2) Pub Date : 2023-12-13 Arsen Shpigelman, Aniela Shouval, Ilai Koder, Shiri Keret, Gleb Slobodin
Background The involvement of facet joints (FJ) in patients with inflammatory rheumatic disorders remains underexplored. This review aims to look at FJ disease from a rheumatologist's perspective, with the emphasis given to the clinical presentations and patterns of FJ engagement in axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), rheumatoid arthritis (RA), and crystal-related arthropathies
-
Febuxostat dose requirement according to renal function in patients who achieve target serum urate levels: a retrospective cohort study Joint Bone Spine (IF 4.2) Pub Date : 2023-11-29 Young-Eun Kim, Soo Min Ahn, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo, Seokchan Hong
Objectives: To determine the febuxostat dose requirement according to renal function in patients who achieve target serum urate (SU) levels Methods: Of 3,153 gout patients who underwent febuxostat treatment, 873 patients with an initial SU level > 6 mg/dL were included and categorized by the estimated glomerular filtration rate: normal, chronic kidney disease (CKD) stage 3, and stages 4-5. 95 patients
-
Evaluation and comparison of oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies Joint Bone Spine (IF 4.2) Pub Date : 2023-11-30 Kim Lauper, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Jacques-Eric Gottenberg, Satoshi Kubo, Merete Lund Hetland, Florenzo Iannone, Eirik K. Kristianslund, Tore K. Kvien, Galina Lukina, Xavier Mariette, Dan C. Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria J. Santos, Yoshiya Tanaka, Carl Turesson, Cem Gabay
Objective: To evaluate and compare the use of oral glucocorticoids with three classes of bDMARDs in patients with rheumatoid arthritis (RA). Methods: We included patients from 13 observational registries treated with a TNF-inhibitor, abatacept or tocilizumab and with available information on the use of oral glucocorticoids. The main outcome was oral glucocorticoid withdrawal. A McNemar test was used
-
Ultrasound in Diagnosis of Cutaneous Sarcoidosis Joint Bone Spine (IF 4.2) Pub Date : 2023-12-01 Avanika Mahajan, Abeer Mousa, Fawad Aslam
Abstract not available
-
Circular RNA circ-3626 promotes bone formation by modulating the miR-338-3p/Runx2 axis Joint Bone Spine (IF 4.2) Pub Date : 2023-11-30 Gaoyang Chen, Song Wang, Ruihong Wei, Yingnan Liu, Tao Xu, Zhaokang Liu, Zhouyong Tan, Yongheng Xie, Dazhi Yang, Zhen Liang, Yongqing Zhuang, Songlin Peng
Objective: Disorders of bone homeostasis are the key factors leading to metabolic bone disease, such as senile osteoporosis, which is characterized by age-related bone loss. Bone marrow stromal cells (BMSCs) possess high osteogenic capacity which has been regarded as a practical approach to preventing bone loss. Previous studies have shown that the osteogenic differentiation ability of BMSCs is significantly
-
Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with biologic or targeted therapies: a meta-analysis of randomized controlled trials Joint Bone Spine (IF 4.2) Pub Date : 2023-11-30 Milène Seauve, Mélanie Auréal, Soline Laplane, Jean-Christophe Lega, Natalia Cabrera, Fabienne Coury
Objective: To evaluate the risk of global infections in patients with psoriatic arthritis (PsA) and axial spondyloarthritis encompassing ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) treated with biologic or targeted therapies. Methods: Medline and Cochrane databases were systematically searched up to March 2021 for randomized controlled trials (RCTs) performed
-
Characteristics of difficult-to-treat axial spondyloarthritis: results of a real-world multicentric study Joint Bone Spine (IF 4.2) Pub Date : 2023-11-29 Cécile Philippoteaux, Thibaut Delepine, Emeline Cailliau, Peggy Philippe, Nicolas Taisne, Tristan Pascart, Bernard Cortet, Julien Paccou, Rene-Marc Flipo, Jean-Guillaume Letarouilly
Objective: The EULAR task force recently published the difficult-to-treat RA (D2T RA) definition, however, a definition of D2T axSpA is still lacking and limitations in this definition exist. The objectives were to study the characteristics of D2T axSpA patients using the EULAR definition and to study a sub-group of patients with a predefined more stringent definition including a temporal criterion
-
Hurdles in new drug development in rheumatic diseases Joint Bone Spine (IF 4.2) Pub Date : 2023-11-30 Frederic Lavie, Terence Rooney
Introduction Rheumatic diseases are heterogenous conditions with multifactorial underlying physiologic pathogeneses. Despite recent progress in the identification and development of advanced therapies primarily focusing on disrupting the immunological abnormalities that cause these conditions, rheumatic disease management remains challenging in a notable proportion of patients, with many exhibiting
-
Osteoarticular manifestations of hyperparathyroidism in a hemodialyzed patient Joint Bone Spine (IF 4.2) Pub Date : 2023-11-28 Arthur Bouchut, Sébastien Ottaviani, Elisabeth Palazzo, Marine Forien, Pierre-Antoine Juge, Florence Vendé, Philippe Dieudé, Esther Ebstein
Abstract not available
-
2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis Joint Bone Spine (IF 4.2) Pub Date : 2023-11-22 Christelle Darrieutort Laffite, Guillaume Coiffier, Florence Aïm, Fréderic Banal, Géraldine Bart, Pascal Chazerain, Marion Couderc, Pascal Coquerelle, Emilie Ducourau Barbary, René-Marc Flipo, Maël Faudemer, Sophie Godot, Céline Hoffmann, Thibaut Lecointe, Christian Lormeau, Denis Mulleman, Jean-Maxime Piot, Eric Senneville, Raphaèle Seror, Christine Voquer, Carine Salliot
Septic bursitis (SB) is a common condition accounting for one third of all cases of inflammatory bursitis. It is often related to professional activities. Management is heterogeneous and either ambulatory or hospital-based, with no recommendations available. This article presents recommendations for managing patients with septic bursitis gathered by 18 rheumatologists from the French Society for Rheumatology
-
Capacity for extra-spinal muscular effort in chronic non-specific low back pain: a cross-sectional case-control study of 192 patients and 335 controls Joint Bone Spine (IF 4.2) Pub Date : 2023-11-15 Thomas Davergne, Amandine Grelier, Agnès Ostertag, Louis Jacob, Pascal Richette, Johann Beaudreuil
Abstract not available
-
The key role of the lymph node niche in the development of rheumatoid arthritis Joint Bone Spine (IF 4.2) Pub Date : 2023-11-15 Marina Jiménez Martínez, Wendy Dankers, Lisa G M Van Baarsen
Abstract not available
-
Pellegrini-Stieda syndrome Joint Bone Spine (IF 4.2) Pub Date : 2023-11-15 Olivier Fakih, Thomas Leriche, Frank Verhoeven, Clément Prati, Daniel Wendling
Abstract not available
-
Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis? Joint Bone Spine (IF 4.2) Pub Date : 2023-11-15 Philippe Goupille, Daniel Wendling
Abstract not available
-
Achilles Tendon Ossification Joint Bone Spine (IF 4.2) Pub Date : 2023-11-04 Esat Kaba, Nur Hürsoy
Abstract not available
-
Effectiveness and safety of rituximab in Takayasu arteritis: data from a multicenter retrospective study Joint Bone Spine (IF 4.2) Pub Date : 2023-10-31 Arsène Mekinian, Lucie Noé, Carlo Salvarani, Lorenzo Dagna, Olivier Espitia, Lucie Biard, José Hernández-Rodríguez, Alessandro Tomelleri, Elena Baldissera, Corrado Campochiaro, Patrice Cacoub, Olivier Fain, David Saadoun
Abstract not available
-
Vertebra plana in Langerhans cell histiocytosis Joint Bone Spine (IF 4.2) Pub Date : 2023-10-17 Parag Vijaysingh Patil
Abstract not available
-
Pulmonary alveolar proteinosis in an adult patient affected by Still’s disease and recurrent episodes of macrophage activation syndrome Joint Bone Spine (IF 4.2) Pub Date : 2023-10-17 Sara Bindoli, Sara Lococo, Fiorella Calabrese, Paolo Sfriso
Abstract not available
-
Ankle retinacula abnormalities as features of psoriatic arthritis: an ultrasound study Joint Bone Spine (IF 4.2) Pub Date : 2023-10-04 Marine Forien, Esther Ebstein, Bastien Léger, Leslie Benattar, Philippe Dieudé, Sébastien Ottaviani
Objective: To compare the ultrasonography (US) assessment of the retinacula of ankles in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Methods: This cross-sectional study included RA or PsA patients with ankle pain and healthy controls. The following US features were recorded: presence of synovitis, tenosynovitis and abnormalities of two retinacula (the superior peroneal retinaculum
-
Anemia and iron deficiency in pregnant women with rheumatic diseases Joint Bone Spine (IF 4.2) Pub Date : 2023-10-04 Ann-Christin Pecher, Samuel Bach, Jan Pauluschke Fröhlich, Harald Abele, Joerg Henes, Melanie Henes
Introduction: Anemia and iron deficiency are the most common pathologies in pregnancy and associated with adverse pregnancy outcome. As patients with rheumatic diseases are also at high risk for anemia, we aimed to investigate the frequency of anemia and iron deficiency during pregnancy in this group and whether anemia is a risk factor for adverse maternal or child outcome. Methods: We analyzed 368